10.1371/journal.pone.0035823 Summary Keywords clinical applications, glycyrrhizin, glycyrrhizin preparations, liver disease, pharmacological mechanisms, safety Citation Ma T, Hao H, Wang S, Qiu D, Cao W, Deng W, Wang S, Li X, Zhang Z, Wei X, Yao L, Gao Z, Yi W, Liu R and Li M (2026) Glycyrrhizin preparations in liver diseases: a narrative review of mechanisms and therapeutic potential
Inject slowly by the intravenous route
R.ShippenD
TNF-alpha-induced self-expression in human lung endothelial cells is inhibited by native and oxidized alpha1-antitrypsin
[DOI] [PubMed] [Google Scholar] 14.Pountos I, Panteli M, Lampropoulos A, Jones E, Calori GM, Giannoudis PV
10.4172/2332-2543.1000121 73 HaqueM